SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Feb. 28, 2025

Accounting Policies [Abstract]

SCHEDULE OF NET INVENTORIES

Net inventories are comprised of approximately the following:

	February 28, 2025			May 31, 2024
Raw materials	$	1,157,000		$	1,519,000
Work in progress		782,000			1,145,000
Finished products		138,000			179,000
Total gross inventory		2,077,000			2,843,000
Inventory reserves		(422,000	)		(467,000	)
Net inventory	$	1,655,000		$	2,376,000

SUMMARY OF OPTIONS ACTIVITY

The following summary presents the options granted, exercised, expired, canceled and outstanding for the nine months ended February 28, 2025:

	Option Shares			Weighted Average Exercise Price
Options Outstanding at May 31, 2024		3,479,616		$	2.53
Granted		429,000			0.35
Exercised		(19,000	)		0.82
Cancelled or expired		(545,750	)		1.68
Options Outstanding at February 28, 2025		3,343,866		$	2.40

SCHEDULE OF RSUs ACTIVITY

The following summary presents the RSUs granted, vested, forfeited and outstanding for the nine months ended February 28, 2025:

	RSUs		Weighted Average Grant Date Fair Value
RSUs Outstanding at May 31, 2024		-	$	-
Granted		780,000		0.31
RSUs Outstanding at February 28, 2025		780,000	$	0.31

SCHEDULE OF DISAGGREGATION REVENUE

The following is a breakdown of revenues according to markets to which the products are sold:

	Three Months Ended				Nine Months Ended
	February 28, 2025		February 29, 2024		February 28, 2025		February 29, 2024
Clinical lab	$	627,000	$	404,000	$	2,683,000	$	2,683,000
Over-the-counter		170,000		329,000		952,000		1,078,000
Contract manufacturing		320,000		281,000		920,000		530,000
Physician’s office		2,000		3,000		7,000		8,000
Total	$	1,119,000	$	1,017,000	$	4,562,000	$	4,299,000